Liberty Mutual Group Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-3,092
| Closed | -$1.25M | – | 615 |
|
|
2018
Q3 | $1.25M | Hold |
3,092
| – | – | 0.03% | 282 |
|
|
2018
Q2 | $1.07M | Buy |
3,092
+30
| +1% | +$10.4K | 0.03% | 346 |
|
|
2018
Q1 | $1.05M | Hold |
3,062
| – | – | 0.03% | 355 |
|
|
2017
Q4 | $1.15M | Sell |
3,062
-24
| -0.8% | -$9.02K | 0.03% | 383 |
|
|
2017
Q3 | $1.38M | Sell |
3,086
-1,690
| -35% | -$756K | 0.08% | 305 |
|
|
2017
Q2 | $2.35M | Buy |
4,776
+721
| +18% | +$354K | 0.1% | 236 |
|
|
2017
Q1 | $1.57M | Sell |
4,055
-1,540
| -28% | -$597K | 0.06% | 445 |
|
|
2016
Q4 | $2.05M | Buy |
5,595
+314
| +6% | +$115K | 0.07% | 347 |
|
|
2016
Q3 | $2.12M | Sell |
5,281
-337
| -6% | -$135K | 0.08% | 304 |
|
|
2016
Q2 | $1.96M | Buy |
5,618
+476
| +9% | +$166K | 0.07% | 313 |
|
|
2016
Q1 | $1.85M | Buy |
5,142
+519
| +11% | +$187K | 0.08% | 304 |
|
|
2015
Q4 | $2.51M | Buy |
4,623
+279
| +6% | +$151K | 0.1% | 270 |
|
|
2015
Q3 | $2.02M | Sell |
4,344
-635
| -13% | -$295K | 0.08% | 325 |
|
|
2015
Q2 | $2.54M | Sell |
4,979
-1,763
| -26% | -$899K | 0.09% | 268 |
|
|
2015
Q1 | $3.04M | Buy |
6,742
+47
| +0.7% | +$21.2K | 0.09% | 235 |
|
|
2014
Q4 | $2.75M | Sell |
6,695
-618
| -8% | -$253K | 0.09% | 272 |
|
|
2014
Q3 | $2.64M | Sell |
7,313
-418
| -5% | -$151K | 0.09% | 278 |
|
|
2014
Q2 | $2.18M | Sell |
7,731
-110
| -1% | -$31.1K | 0.07% | 390 |
|
|
2014
Q1 | $2.36M | Buy |
7,841
+1,016
| +15% | +$305K | 0.08% | 314 |
|
|
2013
Q4 | $1.88M | Buy |
6,825
+2,114
| +45% | +$582K | 0.07% | 368 |
|
|
2013
Q3 | $1.48M | Buy |
4,711
+1,070
| +29% | +$335K | 0.06% | 407 |
|
|
2013
Q2 | $819K | Buy |
+3,641
| New | +$819K | 0.03% | 649 |
|